Filter by: patients
Home > Community Treatment Reports and Side Effects > Levodopa-Benserazide Treatment Report
What is Levodopa-Benserazide?

Levodopa is the precursor molecule to dopamine, an important neurotransmitter implicated in the underlying cause of Parkinson's disease. Benserazide is an additive which allows the levodopa to continue circulating in the body for longer.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Parkinson's Disease 47 14 Efficacy_major Efficacy_moderate Efficacy_slight
Stiffness/Spasticity 6 1 Efficacy_slight
Other 4 2 Efficacy_moderate Efficacy_cant_tell
MSA (Multiple System Atrophy) 3 3 Efficacy_slight Efficacy_cant_tell
Improve mobility 2 0
Slowness 2 0

See all 68 patients currently taking Levodopa-Benserazide

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 2
Moderate
 5
Mild
 6
None
 8

Commonly reported side effects, conditions, and hospitalizations associated with Levodopa-Benserazide

Tiredness 4
Depressed mood 2
Jerky movements (dyskinesia) 1
Dizziness 1
Disordered muscle tension (dystonia) 1
Dry mouth (xerostomia) 1
See all 17 reported side effects ▼ See top 6 reported side effects ▲

Reported Dosages

Frequently reported dosages based on patients currently taking Levodopa-Benserazide. See all 38 dosages ►

  62.5 mg daily 100 mg daily 125 mg daily 250 mg daily 300 mg daily 375 mg daily 500 mg daily 625 mg daily 750 mg daily 1,000 mg daily
  3 Number of Patients: 3 2 Number of Patients: 2 7 Number of Patients: 7 5 Number of Patients: 5 3 Number of Patients: 3 3 Number of Patients: 3 7 Number of Patients: 7 2 Number of Patients: 2 4 Number of Patients: 4 3 Number of Patients: 3  

Reported Stop Reasons

Why Patients Stopped Taking Levodopa-Benserazide (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 5   Other: 42%
Doctor's advice 2   Doctor's advice: 17%
Did not seem to work 2   Did not seem to work: 17%
Not indicated 1   Not indicated: 8%
Side effects too severe 1   Side effects too severe: 8%
Personal research 1   Personal research: 8%
Change in health plan coverage 1   Change in health plan coverage: 8%

See all 12 patients who’ve stopped taking Levodopa-Benserazide

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Levodopa-Benserazide

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Taking Levodopa-Benserazide

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Levodopa-Benserazide

Always
 16 76%
Usually
 3 14%
Sometimes
 0 0%
Never
 2 10%

Burden

Difficulty being on treatment

Burden of Levodopa-Benserazide

Very
 1 5%
Somewhat
 2 10%
A little
 7 33%
Not at all
 11 52%

Cost

Paid out of pocket

Cost of Levodopa-Benserazide

$200+
 1 10%
$100-199
 0 0%
$50-99
 1 10%
$25-49
 2 20%
< $25
 6 60%

Report created on February 11, 2012.